Daily Dividend Report: Apple, Capital One Financial, Yamana Gold, AbbVie, Walgreens Boots Alliance, McKessonForbes • 10/30/20
AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ™ (upadacitinib) in Atopic DermatitisPRNewsWire • 10/29/20
COVID Surges Again: Here Are 7 Resilient, Low-Risk Dividend Aristocrats To Prepare Your PortfolioSeeking Alpha • 10/24/20
5.7% Yielding AbbVie Represents One Of The Fattest Pitches On Wall Street TodaySeeking Alpha • 10/24/20
AbbVie Submits Anti-Inflammatory Drug Rinvoq for FDA, Europe Approval for Atopic DermatitisThe Motley Fool • 10/19/20
AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) in Atopic DermatitisPRNewsWire • 10/19/20